F. Luyckx
La Roche College
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by F. Luyckx.
European Urology | 2011
Bertrand Vayleux; J. Rigaud; F. Luyckx; Georges Karam; Pascal Glemain; Olivier Bouchot; Loïc Le Normand
BACKGROUND The artificial urinary sphincter (AUS) has become a commonly used therapy for severe urinary incontinence (UI) due to intrinsic sphincter deficiency (ISD). OBJECTIVE To evaluate retrospectively the efficacy and risk factors for failure and complications of AUS implantation in women with nonneurologic UI. DESIGN, SETTING, AND PARTICIPANTS From May 1987 to December 2009, 215 women with ISD were treated by AUS implantation, with a mean age of 62.8 yr and a mean follow-up of 6 yr (standard deviation: 5.6 yr). Previous surgical procedures to treat incontinence had been performed in 88.8% of the patients. Urodynamic assessment was required. Patients using only 0 or 1 pad at the end of follow-up were considered continent. The patients level of satisfaction was evaluated by a global analogue scale and clinical interview. INTERVENTION All women had AUS implantation. MEASUREMENTS Patients were evaluated for continence rate, risk factors for failures, and complications. RESULTS AND LIMITATIONS At the end of follow-up, 158 patients (73.5%) were continent, and 170 (79%) were satisfied. The redo rate was 15.3% after a mean interval of 8.47 yr for the first redo procedure. Fifteen explantations (7%) were performed. The only risk factor for intraoperative complications (10.7%) was smoking (p<0.004). Six patients (2.8%) were lost to follow-up. AUS failed to treat incontinence in 51 patients (23.7%) due to defective manipulation in 27.4% of the cases. On multivariate analysis, risk factors for failure were age >70 yr (odds ratio [OR]: 2.46), a history of the Burch procedure (OR: 2.28), or pelvic radiotherapy (OR: 4.37) (p<0.05). CONCLUSIONS The place for this safe and long-lasting effective technique in the treatment of UI due to recurrent sphincter deficiency is confirmed. Screening for these risk factors should allow better patient selection.
Progres En Urologie | 2010
B. Vayleux; F. Luyckx; S. Thélu; J. Rigaud; Olivier Bouchot; Georges Karam; L. Le Normand
OBJECTIVES Evaluation of the results of Adjustable Continence Therapy (ACT) in women by a retrospective one-center study and exposure of a technique: bladder neck retrovision. PATIENTS AND METHODS Between January 2001 and February 2009, 67 women had ACT implantation by the same surgeon for the indication of urinary incontinence by intrinsic sphincter deficiency, with mean age of 70.2 years. Mean follow-up was 24.8 months (1 to 89 months). Evaluation of functional results was realized with the research of urinary leakage when coughing or during abdominal thrust in the clinical exam, with the Urinary Symptom Profile (USP) questionnaire (since 2007), and with an analogical global satisfaction evaluation. RESULTS More than 90% of women (n=67) have been improved at least at one medical consultation, and 60% (40/67) at last follow-up with a satisfaction index superior to 80% in 25 patients. Urinary leakage when coughing or doing abdominal thrust disappeared in 58% (36/62). An improvement of USP score was observed in 76% (19/25). Postoperative complications occurred in 37.3% (25 patients) with a mean period of 10.8 months after surgery. CONCLUSION The ACT, indicated in stress urinary incontinence, is attractive because of the benefit-risk ratio. It could represent an alternative treatment when the artificial urinary sphincter is not technically possible, not accepted or when a reversibility is required. The bladder neck retrovision would improve the ACT surgery by precision and safety.
International Urology and Nephrology | 2018
Y. Chowaniec; F. Luyckx; G. Karam; P. Glemain; J. Dantal; J. Rigaud; J. Branchereau
PurposeTo determine the impact of transplant nephrectomy on morbidity and mortality and HLA immunization.MethodsAll patients who underwent transplant nephrectomy in our centre between 2000 and 2016 were included in this study. A total of 2822 renal transplantations and 180 transplant nephrectomies were performed during this period.ResultsThe indications for transplant nephrectomy were graft intolerance syndrome: 47.2%, sepsis: 22.2%, vascular thrombosis: 15.5%, tumour: 8.3% and other 6.8%. Transplant nephrectomies were performed via an intracapsular approach in 61.7% of cases. The blood transfusion rate was 50%, the morbidity rate was 38% and the mortality rate was 3%. Transplant nephrectomies more than 12 months after renal transplant failure were associated with more complications (p = 0.006). Transfusions in the context of transplant nephrectomy had no significant impact on alloimmunization.ConclusionThe risk of bleeding, and therefore of transfusion, constitutes the major challenge of this surgery in patients eligible for retransplantation. Even if transfusions in this context of transplant nephrectomy had no significant impact on alloimmunization, this high-risk surgery, whenever possible, must be performed electively in a well-prepared patient.
Progres En Urologie | 2017
E. Robine; J. Rigaud; F. Luyckx; Q. Le Clerc; F.-X. Madec; O. Bouchot; J. Branchereau
Male urethral stricture disease is prevalent and has an important impact on quality of life. Direct visual urethrotomy and dilatations have high rates of recurrence. OBJECTIVES The aim of this review of literature was to evaluate the success rates of different techniques of urethroplasty for strictures of the bulbar urethra. METHODS We performed a systematic review of the MEDLINE literature from 2004 to 2015 following the PRISMAs statement recommendations. Key words were: urethroplasty, urethral reconstruction, onlay, graft, urethral stricture. Inclusion criteria were original articles describing the results of urethroplasty for bulbar urethral stricture in an adult male population. A minimum follow-up of 24 months was required. RESULTS From 891 articles of the literature, 20 are studied in this review. Only 3 studies were prospective. The success rate of anastomotic urethroplasty varied from 68.7 to 98.8% for strictures from 1 to 3.5cm, from 60 to 96.9% for augmented urethroplasty performed for strictures from 4.2 to 4.7cm. Substitution urethroplasty with grafts presented from 75 to 89.8% of success for strictures from 2.6 and 4.36cm. Overall, 19/20 studies used buccal mucosal graft. CONCLUSION The success rate of urethroplasty for bulbar urethral stricture is high; the surgical technique should be adapted to the length of the stricture.
Progres En Urologie | 2011
J. Branchereau; F. Luyckx; M. Hitier; Georges Karam; Olivier Bouchot; J. Rigaud
Progres En Urologie | 2010
J. Branchereau; F. Leaute; F. Luyckx; M. Hitier; G. Normand; Georges Karam; Olivier Bouchot; J. Rigaud
Progres En Urologie | 2012
C. Deboudt; J. Branchereau; F. Luyckx; J. Rigaud; Pascal Glemain; Gilles Blancho; Georges Karam
Progres En Urologie | 2011
F. Luyckx; P. Hallouin; C. Barré; G. Aillet; P. Chauveau; J.-F. Hetet; Olivier Bouchot; J. Rigaud
Progres En Urologie | 2010
M. Hitier; L. Marconnet; F. Luyckx; J. Branchereau; Guillaume Braud; Georges Karam; Olivier Bouchot; J. Rigaud
Progres En Urologie | 2017
F.-X. Madec; E. Suply; F. Luyckx; M. Nedelec; Y. Chowaniec; J. Branchereau; L. Le Normand; Pascal Glemain